EU Crunch Time For 15 New Drugs At Final CHMP Meeting Of 2021

Oral Explanation Meetings Possible For Four Marketing Applications

 
• By Neena Brizmohun

Drugs for COVID-19, Alzheimer’s disease and heavy menstrual bleeding due to uterine fibroids are among the latest products that are this week being considered for marketing approval by the European Medicine Agency’s human drugs evaluation committee, the CHMP.

Question marks background. High resolution 3d render
A number of companies are set to find out if their drugs will receive EU approval • Source: Alamy

More from Europe

More from Geography